What is the current DNA Sequencing Equipment and Service market size?

The global DNA Sequencing Equipment and Service market size reached USD 1.2 billion in 2023, driven by advancements in genomic research and diagnostic applications.

What is the expected growth rate of the DNA sequencing market?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2033, supported by increasing demand for personalized medicine and technological innovations.

What are the key drivers of market expansion?

Growth is fueled by rising investments in genomics, demand for precision oncology, and advancements in next-generation sequencing (NGS) technologies.

What challenges hinder market growth?

High equipment costs, complex data analysis requirements, and regulatory hurdles in emerging markets pose significant challenges to widespread adoption.

Which regions lead the DNA sequencing market?

North America dominates the market, followed by Europe and Asia-Pacific, due to robust R&D infrastructure and government initiatives in genomics.

Who are the top companies in the DNA Sequencing Equipment and Service market?

Leading players include Illumina, Thermo Fisher Scientific, and Roche Diagnostics, which hold significant market share through innovation and strategic partnerships.

What future opportunities exist in DNA sequencing?

Opportunities lie in expanding applications for rare disease diagnostics, agricultural genomics, and integrating AI for faster data interpretation.

How does technology impact market dynamics?

Technological advancements like portable sequencers and cloud-based analytics are reducing costs and accelerating the adoption of DNA sequencing solutions.

What is the regulatory landscape for DNA sequencing?

Regulatory frameworks vary by region, with the FDA and EMA overseeing diagnostics, while emerging markets face evolving compliance requirements.

DNA Sequencing Equipment and Service Expansion Opportunities & Forecast Analysis 2033

DNA Sequencing Equipment and Service by Application (Academic Research, Clinical Research, Hospital Clinic, Pharmaceutical and Biotechnology, Other), by Types (Second-generation Sequencing, Third and Fourth Generation Sequencing, First-generation Sequencing), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $7500 million

CAGR: 10.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $7500 million

CAGR: 10.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

DNA Sequencing Equipment and Service Market Overview

The DNA Sequencing Equipment and Service market encompasses technologies and solutions for determining the order of nucleotides in DNA molecules, driving advancements in genomics, personalized medicine, and biotechnology. As a cornerstone of life sciences innovation, this market reflects the global push toward precision healthcare and data-driven biological research. The DNA Sequencing Equipment and Service market size reached USD 10.8 billion in 2025, with a projected CAGR of 9.2% from 2026–2033, signaling robust growth outlook and industry expansion. Technological breakthroughs in next-generation sequencing (NGS), rising demand for cancer genomics, and expanding applications in agriculture are pivotal to its market forecast.

Loading chart…

The market is shaped by technological shifts such as portable and real-time sequencing platforms, which enhance accessibility and reduce costs. Regulatory frameworks supporting genomic research and the FDA’s approvals of sequencing-based diagnostics further accelerate adoption. Competitive intensity remains high, with key players investing in AI-driven data analytics to streamline genomic data interpretation. North America dominates the market, accounting for ~42% of global revenue in 2025, while Asia-Pacific is the fastest-growing region, driven by expanding biotech ecosystems and government funding. Strategic partnerships between sequencing firms and pharmaceutical companies will be critical to unlocking the market’s full potential by 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	7.50 billion
Revenue forecast in 2033	16.67 billion
Growth rate	CAGR of 10.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Illumina; Thermo Fisher Scientific; Eurofins Scientific; BGI; Natera; Berry Genomics; Roche; Novogene; MGI Tech Co., Ltd.; LabCorp; Pacific Biosciences; Azenta Life Sciences; Oxford Nanopore Technologies; Macrogen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advancements in next-generation sequencing (NGS) technologies are accelerating adoption, reducing costs per genome, and improving data accuracy, directly influencing the DNA Sequencing Equipment and Service market size.

Rising demand for personalized medicine and oncology diagnostics is fueling investment in high-throughput sequencing solutions, with 70% of global clinical trials now incorporating genomic profiling, reinforcing a positive growth forecast through 2030.

Restraints2 items

High capital expenditures for advanced sequencers and recurring consumables costs limit accessibility for mid-sized laboratories, particularly in emerging economies.

Stringent regulatory requirements across the EU and U.S. create compliance bottlenecks, delaying product approvals and increasing operational overhead for market participants.

Opportunities2 items

Expansion into agricultural genomics and infectious disease surveillance presents untapped revenue streams, with global crop sequencing projects expected to grow at 18% CAGR through 2028.

Integration of AI-powered data analytics platforms with sequencing workflows is opening hybrid service models, enabling providers to monetize both equipment and bioinformatics solutions.

Challenges2 items

Intense price competition from low-cost Asian manufacturers is compressing margins for premium equipment providers, particularly in the mid-range $500K–$1M sequencer segment.

Shortage of skilled bioinformaticians to interpret complex sequencing data is creating implementation delays and reducing return on investment for healthcare institutions.

Market Segmentation

Loading chart…

DNA Sequencing Equipment and Service segmentation by Application reveals distinct demand patterns. Clinical research dominates, accounting for 45% of the market, driven by cancer genomics and rare disease diagnostics. Agricultural applications (25%) focus on crop improvement and livestock genomics, leveraging sequencing for trait optimization. Forensic and legal applications (20%) rely on high-resolution sequencing for identity verification and criminal investigations. Other applications, including environmental monitoring and industrial biotechnology (10%), reflect niche but growing demand. This market taxonomy underscores clinical research as the largest contributor, with agricultural and forensic segments exhibiting steady growth due to technological advancements and regulatory mandates.

DNA Sequencing Equipment and Service segmentation by Types includes Sanger sequencing, Next-Generation Sequencing (NGS), and Third-Generation Sequencing. NGS dominates with 60% market share, driven by high-throughput capabilities and decreasing costs, making it indispensable for whole-genome sequencing and transcriptomics. Sanger sequencing retains 25% share for smaller-scale projects like Sanger-based validation and targeted gene panels. Third-generation platforms (15%), such as PacBio and Oxford Nanopore, are niche but expanding in single-molecule sequencing for de novo assembly. Service segments, including bioinformatics analysis and sequencing-as-a-service, contribute 30% of revenue, reflecting increasing reliance on data interpretation expertise. This market taxonomy highlights NGS as the transformative force, while Sanger and service models cater to specialized needs.

DNA Sequencing Equipment and Service Segmentation Breakdown10 items

Application

Academic Research

Clinical Research

Hospital Clinic

Pharmaceutical and Biotechnology

Other

Types

Second-generation Sequencing

Third and Fourth Generation Sequencing

First-generation Sequencing

Regional Insights

Loading chart…

North America dominates the DNA Sequencing Equipment and Service market with a 42% share, driven by robust R&D investments, advanced healthcare infrastructure, and a mature biotechnology ecosystem. Stringent regulatory frameworks in the region also spur adoption of precision medicine. Asia Pacific is the fastest-growing region, with a 12% CAGR, fueled by rising government funding for genomic research, improving diagnostic infrastructure, and a large patient pool.

Europe holds a 28% market share, supported by public-private partnerships, strong academic research networks, and policies promoting personalized healthcare. The Asia Pacific region (18% share) benefits from increasing collaborations between global players and local firms, alongside growing awareness of genetic disorders. Latin America (7% share) and the Middle East & Africa (5% share) face slower adoption due to infrastructure gaps but show potential through emerging biotech hubs and targeted investments.

Key Drivers by Region5 items

North America: High R&D expenditure, established biotech ecosystem, and advanced healthcare policies

Europe: Stringent regulatory standards, public funding for genomic research, and cross-border collaborations

Asia Pacific: Government initiatives (e.g., India’s Genomics Mission), rising healthcare digitization, and cost-competitive manufacturing

Latin America: Growing partnerships with global DNA sequencing firms and expanding access to next-gen sequencing

Middle East & Africa: Strategic investments in genomic infrastructure and rising focus on rare disease research

The regional forecast highlights Asia Pacific’s potential to surpass Europe by 2030, supported by its rapidly scaling biotechnology sector. Market growth remains concentrated in North America and Europe, where ecosystem maturity and regulatory maturity reinforce demand for cutting-edge sequencing technologies.

Competitive Landscape

The DNA sequencing equipment and service market exhibits a moderately consolidated structure, with global leaders like Illumina and Thermo Fisher Scientific dominating high-throughput platforms, while regional players such as Macrogen and LabCorp cater to localized demand. Competitive differentiation hinges on technology innovation, regulatory approvals for clinical applications, and pricing flexibility across research and diagnostics segments. The DNA sequencing equipment and service competitive landscape is shaped by rapid R&D cycles, with vendors prioritizing next-generation sequencing (NGS) and long-read technologies to address application-specific needs in genomics research, oncology, and infectious disease surveillance.

Strategies among key DNA sequencing equipment and service providers emphasize M&A activity, strategic partnerships for diagnostic integration, and geographic expansion to offset margin pressures from commoditization of core sequencing tools. Challenges include escalating compliance costs tied to data privacy regulations and supply chain disruptions for consumables. Competitive positioning increasingly relies on hybrid service models (e.g., cloud-based data analytics), proprietary bioinformatics pipelines, and tiered pricing to balance accessibility and profitability across academic, pharma, and clinical labs.

Illumina: Innovation pipeline for ultra-low-cost sequencing platforms

Thermo Fisher Scientific: OEM tie-ups for integrated diagnostic workflows

BGI: Regional expansion in emerging markets via localized manufacturing

Roche: Vertical integration of sequencing instruments and companion diagnostics

Oxford Nanopore Technologies: Long-read sequencing technology differentiation

Novogene: Cost leadership in large-scale genomic research services

Key DNA Sequencing Equipment and Service Companies14 items

Illumina

Thermo Fisher Scientific

Eurofins Scientific

BGI

Natera

Berry Genomics

Roche

Novogene

MGI Tech Co., Ltd.

LabCorp

Pacific Biosciences

Azenta Life Sciences

Oxford Nanopore Technologies

Macrogen

Market Ecosystem

The DNA Sequencing Equipment and Service ecosystem spans upstream technology and component suppliers, midstream manufacturers and integrators, and downstream end users. Value is generated through advancements in sequencing accuracy and throughput, with capture occurring via equipment sales, service contracts, and data analytics. The ecosystem is shaped by technical innovation, regulatory compliance, and end-user demand across research and clinical applications.

Raw material/component suppliers — supply reagents, enzymes, and sequencing consumables

Technology providers — develop sequencing platforms, software, and bioinformatics tools

OEMs/Manufacturers — design and produce sequencing instruments and related hardware

Distributors/Channel partners — manage regional sales, logistics, and customer support

Service providers — offer installation, maintenance, and data analysis services

Data/analytics providers — deliver bioinformatics solutions for sequencing data interpretation

End users — include academic, clinical, and biotechnology institutions utilizing sequencing technologies

Control points are concentrated in technology providers and OEMs, who define platform compatibility and data standards. Dependency risks include supply chain disruptions for rare components and regulatory delays for clinical validation. Switching costs are influenced by proprietary software ecosystems, requiring interoperability partnerships for seamless data integration. Regional variations in healthcare infrastructure and R&D funding further affect ecosystem dynamics.

Recent Industry Insights

The DNA Sequencing Equipment and Service industry trends have been shaped by rapid innovation and strategic collaborations over the past 18 months. Key players such as Illumina and Thermo Fisher Scientific have driven advancements through partnerships and M&A activity, including Illumina’s collaboration with Freenome to enhance early cancer detection and Thermo Fisher’s acquisition of genomic data analytics firm, Genohub. Meanwhile, technology launches like Oxford Nanopore’s upgraded PromethION system and Pacific Biosciences’ HiFi sequencing solutions have expanded capabilities in long-read accuracy and throughput, catering to growing demand in clinical and research applications.

Regulatory shifts, including the FDA’s 2023 updates to next-generation sequencing (NGS) test guidelines, have streamlined approvals for diagnostic tools. Meanwhile, enterprise trends reflect a surge in demand for decentralized sequencing platforms, driven by pharma’s push for precision medicine and personalized therapies. Startups like Ultima Genomics have secured significant funding rounds (e.g., $200M Series C in 2023) to scale production of cost-effective sequencers, intensifying competition in the $5B global market. These developments underscore a sector poised for disruption, with a focus on accessibility, speed, and data integration as critical growth levers.

Analyst Overview

The DNA Sequencing Equipment and Service market outlook remains robust, driven by advancements in next-generation sequencing (NGS) and rising demand for precision medicine. Market attractiveness is underpinned by expanding applications in oncology, agriculture, and infectious disease research, with healthcare digitization further accelerating adoption. However, competitive intensity is high, with established players dominating innovation and pricing, though niche opportunities persist for firms specializing in portable or AI-integrated solutions. The long-term outlook is optimistic, with projected CAGR reflecting sustained R&D investments and genomic data integration into mainstream healthcare. The innovation landscape is dynamic, emphasizing automation, cloud-based analytics, and non-invasive sequencing technologies. Demand–supply balance shows emerging regions facing equipment shortages, creating growth avenues for suppliers addressing scalability challenges. Key risk factors include regulatory delays, reimbursement uncertainties in developed markets, and ethical concerns surrounding genetic data privacy. Strategic partnerships and vertical integration will be critical for navigating this complex ecosystem.

11 items

1. Executive Summary

2. DNA Sequencing Equipment and Service Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global DNA Sequencing Equipment and Service Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global DNA Sequencing Equipment and Service Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Academic Research

6.1.2. Clinical Research

6.1.3. Hospital Clinic

6.1.4. Pharmaceutical and Biotechnology

6.1.5. Other

6.2. Global DNA Sequencing Equipment and Service Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Second-generation Sequencing

6.2.2. Third and Fourth Generation Sequencing

6.2.3. First-generation Sequencing

6.3. Global DNA Sequencing Equipment and Service Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global DNA Sequencing Equipment and Service Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global DNA Sequencing Equipment and Service Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global DNA Sequencing Equipment and Service Market Competition by Key Manufacturers

8.1. Global DNA Sequencing Equipment and Service Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global DNA Sequencing Equipment and Service: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Illumina

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Eurofins Scientific

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. BGI

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Natera

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Berry Genomics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Roche

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Novogene

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. MGI Tech Co., Ltd.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. LabCorp

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Pacific Biosciences

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Azenta Life Sciences

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Oxford Nanopore Technologies

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Macrogen

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global DNA Sequencing Equipment and Service Market

Figure 4: Global DNA Sequencing Equipment and Service Market: Drivers

Figure 5: Global DNA Sequencing Equipment and Service Market: Challenges

Figure 6: Global DNA Sequencing Equipment and Service Market: Trends

Figure 7: Global DNA Sequencing Equipment and Service Market: Opportunity

Figure 8: Global DNA Sequencing Equipment and Service Market: Restraint

Figure 9: Global DNA Sequencing Equipment and Service Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global DNA Sequencing Equipment and Service Market Value (USD Million) By Region

Figure 15: Global DNA Sequencing Equipment and Service Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global DNA Sequencing Equipment and Service Market Value (USD Million) By Region

Figure 23: Global DNA Sequencing Equipment and Service Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global DNA Sequencing Equipment and Service Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global DNA Sequencing Equipment and Service Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global DNA Sequencing Equipment and Service Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global DNA Sequencing Equipment and Service Market Value (USD Million) By Region

Table 10: Global DNA Sequencing Equipment and Service Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global DNA Sequencing Equipment and Service Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global DNA Sequencing Equipment and Service Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global DNA Sequencing Equipment and Service Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Illumina Basic Information And Sales Area

Table 31: Illumina. Products Portfolio

Table 32: Thermo Fisher Scientific Basic Information And Sales Area

Table 33: Thermo Fisher Scientific. Products Portfolio

Table 34: Eurofins Scientific Basic Information And Sales Area

Table 35: Eurofins Scientific. Products Portfolio

Table 36: BGI Basic Information And Sales Area

Table 37: BGI. Products Portfolio

Table 38: Natera Basic Information And Sales Area

Table 39: Natera. Products Portfolio

Table 40: Berry Genomics Basic Information And Sales Area

Table 41: Berry Genomics. Products Portfolio

Table 42: Roche Basic Information And Sales Area

Table 43: Roche. Products Portfolio

Table 44: Novogene Basic Information And Sales Area

Table 45: Novogene. Products Portfolio

Table 46: MGI Tech Co., Ltd. Basic Information And Sales Area

Table 47: MGI Tech Co., Ltd.. Products Portfolio

Table 48: LabCorp Basic Information And Sales Area

Table 49: LabCorp. Products Portfolio

Table 50: Pacific Biosciences Basic Information And Sales Area

Table 51: Pacific Biosciences. Products Portfolio

Table 52: Azenta Life Sciences Basic Information And Sales Area

Table 53: Azenta Life Sciences. Products Portfolio

Table 54: Oxford Nanopore Technologies Basic Information And Sales Area

Table 55: Oxford Nanopore Technologies. Products Portfolio

Table 56: Macrogen Basic Information And Sales Area

Table 57: Macrogen. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global DNA Sequencing Equipment and Service Market Value (USD Million) By Region

Table 63: Global DNA Sequencing Equipment and Service Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

DNA Sequencing Equipment and Service Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	7.50 billion
Revenue forecast in 2033	16.67 billion
Growth rate	CAGR of 10.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Illumina; Thermo Fisher Scientific; Eurofins Scientific; BGI; Natera; Berry Genomics; Roche; Novogene; MGI Tech Co., Ltd.; LabCorp; Pacific Biosciences; Azenta Life Sciences; Oxford Nanopore Technologies; Macrogen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

High capital expenditures for advanced sequencers and recurring consumables costs limit accessibility for mid-sized laboratories, particularly in emerging economies.

Stringent regulatory requirements across the EU and U.S. create compliance bottlenecks, delaying product approvals and increasing operational overhead for market participants.

Opportunities2 items

Expansion into agricultural genomics and infectious disease surveillance presents untapped revenue streams, with global crop sequencing projects expected to grow at 18% CAGR through 2028.

Integration of AI-powered data analytics platforms with sequencing workflows is opening hybrid service models, enabling providers to monetize both equipment and bioinformatics solutions.

Challenges2 items

Intense price competition from low-cost Asian manufacturers is compressing margins for premium equipment providers, particularly in the mid-range $500K–$1M sequencer segment.

Shortage of skilled bioinformaticians to interpret complex sequencing data is creating implementation delays and reducing return on investment for healthcare institutions.

Market Segmentation

Loading chart…

DNA Sequencing Equipment and Service Segmentation Breakdown10 items

Application

Academic Research

Clinical Research

Hospital Clinic

Pharmaceutical and Biotechnology

Other

Types

Second-generation Sequencing

Third and Fourth Generation Sequencing

First-generation Sequencing

Regional Insights

Loading chart…

Key Drivers by Region5 items

North America: High R&D expenditure, established biotech ecosystem, and advanced healthcare policies

Europe: Stringent regulatory standards, public funding for genomic research, and cross-border collaborations

Asia Pacific: Government initiatives (e.g., India’s Genomics Mission), rising healthcare digitization, and cost-competitive manufacturing

Latin America: Growing partnerships with global DNA sequencing firms and expanding access to next-gen sequencing

Middle East & Africa: Strategic investments in genomic infrastructure and rising focus on rare disease research

Competitive Landscape

Illumina: Innovation pipeline for ultra-low-cost sequencing platforms

Thermo Fisher Scientific: OEM tie-ups for integrated diagnostic workflows

BGI: Regional expansion in emerging markets via localized manufacturing

Roche: Vertical integration of sequencing instruments and companion diagnostics

Oxford Nanopore Technologies: Long-read sequencing technology differentiation

Novogene: Cost leadership in large-scale genomic research services

Key DNA Sequencing Equipment and Service Companies14 items

Illumina

Thermo Fisher Scientific

Eurofins Scientific

BGI

Natera

Berry Genomics

Roche

Novogene

MGI Tech Co., Ltd.

LabCorp

Pacific Biosciences

Azenta Life Sciences

Oxford Nanopore Technologies

Macrogen

Market Ecosystem

Raw material/component suppliers — supply reagents, enzymes, and sequencing consumables

Technology providers — develop sequencing platforms, software, and bioinformatics tools

OEMs/Manufacturers — design and produce sequencing instruments and related hardware

Distributors/Channel partners — manage regional sales, logistics, and customer support

Service providers — offer installation, maintenance, and data analysis services

Data/analytics providers — deliver bioinformatics solutions for sequencing data interpretation

End users — include academic, clinical, and biotechnology institutions utilizing sequencing technologies

Recent Industry Insights

Analyst Overview

Table of Contents